- Trials with a EudraCT protocol (45)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
45 result(s) found for: Radical Hysterectomy.
Displaying page 1 of 3.
EudraCT Number: 2006-005518-11 | Sponsor Protocol Number: 2006-10 | Start Date*: 2007-01-24 |
Sponsor Name:Örebro University Hospital | ||
Full Title: Epidural analgesia or opatient controlled regional analgesia for radical Retropubic Prostatectomy. A randomized, double-blind study. | ||
Medical condition: Postoperative pain after radical retropubic prostatectomy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2012-005407-40 | Sponsor Protocol Number: 2011-425 | Start Date*: 2013-02-07 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Thomas Bergholt | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: Peroperative Tranexamic acid as prophylaxis of bleeding related to benign hysterectomy - a randomized, placebo-controlled trial | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Bleeding related to benign hysterectomy | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Female | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2005-004055-35 | Sponsor Protocol Number: Bay a 0128/12002 | Start Date*: 2006-01-02 | |||||||||||
Sponsor Name:Bayer HealthCare AG | |||||||||||||
Full Title: A multi-center, randomized, double blind, placebo controlled study to investigate the efficacy and safety of Aprotinin on transfusion requirements in patients with bladder cancer undergoing radical... | |||||||||||||
Medical condition: Radical or total cystectomy on patients with bladder cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) BE (Completed) SE (Prematurely Ended) GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-002251-33 | Sponsor Protocol Number: 01 | Start Date*: 2006-10-10 |
Sponsor Name:University of Vienna | ||
Full Title: Hypoxia Imaging with the novel Radiopharmaceutical 18F Fluoroazomycin Arabinoside (FAZA)- Prognostic impact in Cervical Cancer . | ||
Medical condition: Twenty-five patients with cervical carcinoma (T2Nx or TxN1) will be included in the present study. In addition to the routine pre-therapeutical staging of cervical cancer, 18FAZA PET will be perfor... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2020-002244-23 | Sponsor Protocol Number: INCB24360-901 | Start Date*: 2021-10-13 | ||||||||||||||||
Sponsor Name:INCYTE CORPORATION | ||||||||||||||||||
Full Title: An Open-Label, Randomized, Phase 2, Umbrella Study of Various Neoadjuvant Therapies for Participants With Muscle-Invasive Urothelial Carcinoma of the Bladder Who Are Cisplatin-Ineligible or Refuse ... | ||||||||||||||||||
Medical condition: Muscle-Invasive Urothelial Carcinoma of the Bladder Who Are Cisplatin-Ineligible or Refuse Cisplatin Therapy and Undergoing Radical Cystectomy | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-001216-19 | Sponsor Protocol Number: | Start Date*: 2014-11-13 |
Sponsor Name:NHS Greater Glasgow & Clyde [...] | ||
Full Title: Short-course radiotherapy plus olaparib for newly diagnosed glioblastoma in patients unsuitable for radical chemoradiation: a randomised phase II clinical trial preceded by a lead-in phase I dose e... | ||
Medical condition: glioblastoma | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2014-004867-19 | Sponsor Protocol Number: v1330032015 | Start Date*: 2015-02-24 |
Sponsor Name:Clinic for General Anesthesiology, Intensive Care and Pain Management | ||
Full Title: Perioperative fluid management in patients receiving major abdominal surgery – Effects of normal saline versus an acetate buffered balanced infusion solution on the necessity of catecholamines for ... | ||
Medical condition: hemodynamic stability of patients undergoing major surgery | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: AT (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2021-004562-35 | Sponsor Protocol Number: Ketolorac_001 | Start Date*: 2021-11-25 | ||||||||||||||||
Sponsor Name:Jessa ziekenhuis vzw | ||||||||||||||||||
Full Title: Low dose versus normal dose ketorolac for postoperative pain after prostatectomy and hysterectomy: a Double-blind Randomized Controlled Non-inferiority Trial | ||||||||||||||||||
Medical condition: Prostatectomy Hysterectomy | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: BE (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-002620-36 | Sponsor Protocol Number: 17000139BLC3001 | Start Date*: 2021-05-21 | ||||||||||||||||||||||||||
Sponsor Name:Janssen-Cilag International NV | ||||||||||||||||||||||||||||
Full Title: A Phase 3, Multi-center, Randomized Study Evaluating Efficacy of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-Invasive Urothelial Carcinoma... | ||||||||||||||||||||||||||||
Medical condition: Muscle-Invasive Urothelial Carcinoma (MIBC) of the Bladder | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: DE (Ongoing) FR (Completed) PT (Ongoing) AT (Ongoing) PL (Completed) BE (Ongoing) HU (Ongoing) GR (Ongoing) CZ (Trial now transitioned) IT (Ongoing) ES (Ongoing) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-023081-52 | Sponsor Protocol Number: ENGOT-EN2-DGCG | Start Date*: 2011-01-25 | ||||||||||||||||
Sponsor Name:Danish Gynaecological Cancer Group (DGCG) | ||||||||||||||||||
Full Title: A phase II Trial of postoperative chemotherapy or no further treatment for patients with node-negative stage I-II intermediate or high risk endometrial cancer. | ||||||||||||||||||
Medical condition: Endometrial cancer | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Female | |||||||||||||||||
Trial protocol: DK (Ongoing) SE (Ongoing) BE (Ongoing) FI (Ongoing) AT (Ongoing) GB (GB - no longer in EU/EEA) ES (Ongoing) DE (Ongoing) IT (Ongoing) NL (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-011542-25 | Sponsor Protocol Number: C-2009-01 | Start Date*: 2010-01-07 | ||||||||||||||||
Sponsor Name:NHS Greater Glasgow and Clyde [...] | ||||||||||||||||||
Full Title: CIRCCa(Cediranib In Recurrent Cervical Cancer) A Randomised Double Blind Phase II trial of carboplatin-paclitaxel plus cediranib versus carboplatin-paclitaxel plus placebo in metastatic/recurrent c... | ||||||||||||||||||
Medical condition: Metastatic/ Recurrent carinoma of cervix | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Female | |||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2008-006214-26 | Sponsor Protocol Number: GU07-123 | Start Date*: 2009-09-07 |
Sponsor Name:Hoosier Oncology Group | ||
Full Title: Phase II Trial of Neoadjuvent Cisplatin, Gemcitabine and Sunitinib Malate followed by radical cystectomy for transitional Cell Carcinoma (TCC) of the bladder | ||
Medical condition: operable bladder cancer (T2 to T4a) lymph node negative disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2015-005504-28 | Sponsor Protocol Number: EORTC-1525-LCG | Start Date*: 2017-12-19 | |||||||||||
Sponsor Name:European Organisation for Research and Treatment of Cancer | |||||||||||||
Full Title: Single-arm, multicenter, phase II study of immunotherapy in patients with type B3 thymoma and thymic carcinoma previously treated with chemotherapy - (Nivothym) | |||||||||||||
Medical condition: type B3 thymoma and thymic carcinoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Ongoing) ES (Temporarily Halted) NL (Restarted) GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-004585-18 | Sponsor Protocol Number: KKS-190 | Start Date*: 2013-08-27 | |||||||||||||||||||||
Sponsor Name:Philipps-Universität Marburg | |||||||||||||||||||||||
Full Title: Perioperative administration of Tapentadol – tolerance, safety and effects on postoperative rehabilitation and quality of life. Randomized, controlled study to compare the analgesic therapy with t... | |||||||||||||||||||||||
Medical condition: Hysterectomy with ASA 1-3, Prostatectomy with ASA 1-3, Nephrectomy with ASA 1-3 | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: DE (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2016-002824-98 | Sponsor Protocol Number: ANE_HEPUNOX | Start Date*: 2016-10-20 | |||||||||||
Sponsor Name:Fundació Hospital Vall Hebron Institut de Recerca | |||||||||||||
Full Title: Comparison of three techniques in the management of the postoperatory acute pain, after a general anesthesia based on the control of the nociception. | |||||||||||||
Medical condition: Acute postoperative pain | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-002678-11 | Sponsor Protocol Number: ICO-13-001 | Start Date*: 2018-06-07 |
Sponsor Name:Institut Català d’Oncologia | ||
Full Title: An open label biomarker pilot study of the antitumoral acrivity of denosumab in the pre-operative setting of early breast cancer | ||
Medical condition: early breast cancer | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: View results |
EudraCT Number: 2022-000601-27 | Sponsor Protocol Number: MERCURY | Start Date*: 2022-09-27 | |||||||||||
Sponsor Name:Fondazione GONO | |||||||||||||
Full Title: Window-of-opportunity study of chemo-immunotherapy in patients with resectable Merkel Cell Carcinoma prior to surgery: the MERCURY trial | |||||||||||||
Medical condition: The disease under clinical investigation is represented by resectable Merkel Cell Carcinoma (MCC), stage IIA-III (according to the AJCC staging system 8th edition). The study will include patients ... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-002816-22 | Sponsor Protocol Number: CTL-002-002 | Start Date*: 2023-03-09 | |||||||||||
Sponsor Name:Catalym GmbH | |||||||||||||
Full Title: A multi-center Phase 2 study of neoadjuvant immunotherapy in combination with the anti-GDF-15 antibody visugromab (CTL-002) for the treatment of muscle invasive bladder cancer | |||||||||||||
Medical condition: Muscle invasive bladder cancer set to undergo radical cystectomy who cannot receive or refuse to receive cisplatin-based chemotherapy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-003102-40 | Sponsor Protocol Number: M17CPF | Start Date*: 2018-11-01 | |||||||||||
Sponsor Name:NKI-AVL | |||||||||||||
Full Title: Neo-Adjuvant Chemotherapy and Conservative Surgery in Cervical Cancer to Preserve Fertility | |||||||||||||
Medical condition: women ≥18 and ≤ 40 years with FIGO stage Ib1 cervical carcinoma with tumor measuring ≥ 2 cm and ≤ 4 cm on physical examination and imaging | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: NL (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-000994-69 | Sponsor Protocol Number: SOV302 | Start Date*: 2004-11-11 | |||||||||||
Sponsor Name:Amersham Buchler GmbH & Co KG an affiliate of GE Healthcare Bio-Sciences | |||||||||||||
Full Title: A multicentre, phase 3, open label study to assess the efficacy and safety of 0.1 mmol/kg Omniscan™ (gadodiamide injection) for Magnetic Resonance Angiography (MRA) of the aorto-iliac arteries | |||||||||||||
Medical condition: Suspected or proven chronic PAOD predominantly located in the aorto-iliac region of Fontaine Stages IIb to IV (ie, Rutherford Stages I3-III), or presents with an ankle brachial pressure index of <0... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) SE (Completed) BE (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.